Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases
- 1 July 2021
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (7), 1528-1534
- https://doi.org/10.1002/lary.29364
Abstract
Objective/Hypothesis: Testicular cancer is the most common malignancy of young males. Limited reports describe perioperative and long-term outcomes after surgical resection of metastatic, cervical, non-seminomatous germ cell tumors (NSGCT). The objective of this study was to investigate the effectiveness and safety of cervical lymphadenectomy in the management of metastatic NSGCT. Study Design: Retrospective case series. Methods: A single institution, retrospective review from 1998 to 2020 of patients with metastatic NSGCT who underwent cervical lymphadenectomy was conducted. Clinicopathological, surgical, and postoperative data were collected and analyzed. Results: Sixty-eight predominantly white (91.0%) male patients with mean age 33.0 +/- 11.3 years were included. Most (82.2%) presented with stage III disease at initial diagnosis. All patients had undergone primary platinum-based chemotherapy 1.0 to 22.7 months prior to selective ND. Surgery mainly involved nodal levels III (67.6%), IV (92.6%) and/or Vb (77.9%) and was frequently performed with concomitant thoracoabdominal NSGCT resections (63.2%). Cervical specimens predominantly revealed mature teratoma (83.8%) as solitary (69.1%) or component of mixed (14.7%) NSGCT. Ten (14.7%) perioperative complications occurred as vocal cord paresis (n = 6) from thoracic surgery and chyle leakage (n = 4). All resolved conservatively except two vocal cord paralyzes that required surgical repair due to tumor involvement of vagus nerve. Six instances of cervical recurrence occurred at median 12.5 (range, 5.8-38.6) months from ND, all re-demonstrating purely mature teratoma. The two-year cervical, non-cervical, and overall recurrence-free survivals were 83%, 55%, and 55%, respectively. Two-year disease-free and overall survivals were both 93%. Conclusions: Selective neck dissection is a safe, effective method for managing cervical NSGCT metastases.This publication has 32 references indexed in Scilit:
- The surgical anatomy and clinical relevance of the neglected right lymphatic duct: reviewThe Journal of Laryngology & Otology, 2013
- Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or MediastinumThe Annals of Thoracic Surgery, 2011
- Cervical Lymph Node Dissection for Metastatic Testicular CancerAnnals of Surgical Oncology, 2010
- Retroperitoneal lymph node dissection after chemotherapyBJU International, 2009
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part IIEuropean Urology, 2008
- Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysisEuropean Journal of Cancer, 2006
- Late recurrence in 1263 men with testicular germ cell tumorsCancer, 2002
- Metastatic nonseminomatous germ cell tumors of the testisCancer, 2002
- Modified Neck Dissection for Metastatic Nonseminomatous Testicular CarcinomaThe Laryngoscope, 1999
- Incidence and Management of Testicular Carcinoma Metastatic to the NeckJournal of Urology, 1996